Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
Romain Eychenne, Christelle Bouvry, Mickaël Bourgeois, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 4012-4012
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Opportunities and challenges of RiPP-based therapeutics
I. Pfeiffer, M. Schröder, Silja Mordhorst
Natural Product Reports (2024) Vol. 41, Iss. 7, pp. 990-1019
Open Access | Times Cited: 20
Carrier systems of radiopharmaceuticals and the application in cancer therapy
Taotao Zhang, Huiwen Lei, Xiaohua Chen, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals?
Nicolas Lepareur
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 39
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 34
Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review
Paul Gape, Michael K. Schultz, Graeme J. Stasiuk, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 334-334
Open Access | Times Cited: 14
PET imaging of 52Mn labeled DOTATATE and DOTAJR11
James M. Omweri, Hailey Houson, Shannon E. Lynch, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study
A. А. Medvedeva, В. И. Чернов, M. S. Larkina, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 736-747
Open Access | Times Cited: 1
Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma
Emirhan Harbi, Michael Aschner
Journal of Neuroendocrinology (2025)
Closed Access | Times Cited: 1
The role of fusion proteins as biomarkers and therapeutic agents for Alzheimer's disease: A narrative review
Dessy Agustini, Rohan Sabloak, Shemonti Hasan, et al.
NeuroMarkers. (2025) Vol. 2, Iss. 2, pp. 100041-100041
Open Access | Times Cited: 1
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy
Cristina Barca, Christoph M. Griessinger, Andreas Faust, et al.
Pharmaceuticals (2021) Vol. 15, Iss. 1, pp. 13-13
Open Access | Times Cited: 42
Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
Melpomeni Fani, Rosalba Mansi, Guillaume Nicolas, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1172-1172
Open Access | Times Cited: 36
Structural insights into ligand recognition and selectivity of somatostatin receptors
Wenli Zhao, Shuo Han, Na Qiu, et al.
Cell Research (2022) Vol. 32, Iss. 8, pp. 761-772
Open Access | Times Cited: 32
Neuroendocrine tumor theranostics
Yasushi Ichikawa, Noritoshi Kobayashi, Shoko Takano, et al.
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1930-1938
Open Access | Times Cited: 30
Ocular immune privilege and retinal pigment epithelial cells
Yuxiang Du, Bo Yan
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 3, pp. 288-304
Open Access | Times Cited: 22
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours
Damian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 1, pp. 183-195
Open Access | Times Cited: 20
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
Berthold A. Nock, Panagiotis Kanellopoulos, Lieke Joosten, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 674-674
Open Access | Times Cited: 18
Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
Valentina Ambrosini, Lucia Zanoni, Angelina Filice, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1055-1055
Open Access | Times Cited: 27
Clinical application of 99mTc‐labeled peptides for tumor imaging: Current status and future directions
Jiyun Shi, S. Liu
iRadiology (2024) Vol. 2, Iss. 1, pp. 17-34
Open Access | Times Cited: 5
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours
Seval Beykan Schürrle, Uta Eberlein, C. Ansquer, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 8, pp. 2428-2441
Open Access | Times Cited: 5
In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism
Valery M. Dembitsky
Marine Drugs (2021) Vol. 19, Iss. 11, pp. 650-650
Open Access | Times Cited: 30
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy
Susanna C. Concilio, Stephen J. Russell, Kah-Whye Peng
Molecular Therapy — Oncolytics (2021) Vol. 21, pp. 98-109
Open Access | Times Cited: 24
Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions
María Isabel del Olmo-García, S. Prado-Wohlwend, Pilar Belló, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 584-584
Open Access | Times Cited: 18
Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT
Rexhep Durmo, Angelina Filice, Federica Fioroni, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 592-592
Open Access | Times Cited: 18
Neuropeptides in Cancer: Friend and Foe?
Yue Wu, Adrian Berisha, Jeremy C. Borniger
Advanced Biology (2022) Vol. 6, Iss. 9
Closed Access | Times Cited: 18
Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
Aadil Adnan, Sandip Basu
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2154-2154
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top